To the best of our knowledge, we demonstrated for the first time that TCD induced apoptotic death in breast cancer cells through Akt-NF-κB signaling, reactive oxygen species (ROS) production, and histone deacetylase inhibition. This evidence concerns the gene NFKB1 and breast carcinoma.